Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 276-279
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.276
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.276
Table 2 Incidence of cholangitis and bacteremia in two study groups
| Complication | Ciprofloxacin post-ERCP | Relative risk | 95% CI | |
| Yes (n = 22) | No (n = 26) | |||
| Cholangitis | 1 (4.5%) | 2 (7.7%) | 0.71 | 0.14-3.65 |
| Bacteremia | 13 (59.1%) | 14 (53.8%) | 1.12 | 0.60-2.11 |
- Citation: Ratanachu-ek T, Prajanphanit P, Leelawat K, Chantawibul S, Panpimanmas S, Subwongcharoen S, Wannaprasert J. Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2007; 13(2): 276-279
- URL: https://www.wjgnet.com/1007-9327/full/v13/i2/276.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i2.276